Divergent modulation of Src-family kinase regulatory interactions with ATP-competitive inhibitors

ACS Chemical Biology

Volumn 9, Issue 8, 2014, Pages 1894-1905

  Leonard, Stephen E ^a   Register, A C ^a   Krishnamurty, Ratika ^a   Brighty, Gabriel J ^a   Maly, Dustin J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEMATOPOIETIC CELL KINASE; PROTEIN TYROSINE KINASE; LIGAND;

ALPHA HELIX; ARTICLE; BINDING SITE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; ENZYME MECHANISM; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; METABOLISM; PHOSPHORYLATION;

ADENOSINE TRIPHOSPHATE; LIGANDS; PHOSPHORYLATION; SRC-FAMILY KINASES;

EID: 84906248043     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500371g     Document Type: Article

References (60)

1. Taylor, S. S. and Kornev, A. P. (2011) Protein kinases: evolution of dynamic regulatory proteins Trends Biochem. Sci. 36, 65-77
2. Hubbard, S. R. and Till, J. H. (2000) Protein tyrosine kinase structure and function Annu. Rev. Biochem. 69, 373-398
3. Bhattacharyya, R. P., Remenyi, A., Yeh, B. J., and Lim, W. A. (2006) Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits Annu. Rev. Biochem. 75, 655-680
4. Kuriyan, J. and Eisenberg, D. (2007) The origin of protein interactions and allostery in colocalization Nature 450, 983-990
5. Pellicena, P. and Kuriyan, J. (2006) Protein-protein interactions in the allosteric regulation of protein kinases Curr. Opin. Struct. Biol. 16, 702-709
6. Rauch, J., Volinsky, N., Romano, D., and Kolch, W. (2011) The secret life of kinases: functions beyond catalysis Cell Commun. Signaling 9, 23
7. Frame, M. C. (2002) Src in cancer: deregulation and consequences for cell behaviour Biochim. Biophys. Acta 1602, 114-130
8. Chong, Y. P., Ia, K. K., Mulhern, T. D., and Cheng, H. C. (2005) Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases Biochim. Biophys. Acta 1754, 210-220
9. Parsons, S. J. and Parsons, J. T. (2004) Src family kinases, key regulators of signal transduction Oncogene 23, 7906-7909
10. Summy, J. M. and Gallick, G. E. (2003) Src family kinases in tumor progression and metastasis Cancer Metastasis Rev. 22, 337-358
11. Sen, B. and Johnson, F. M. (2011) Regulation of SRC family kinases in human cancers J. Signal Transduction 2011, 865819
12. Guarino, M. (2010) Src signaling in cancer invasion J. Cell. Physiol. 223, 14-26
13. Jura, N., Zhang, X., Endres, N. F., Seeliger, M. A., Schindler, T., and Kuriyan, J. (2011) Catalytic control in the EGF receptor and its connection to general kinase regulatory mechanisms Mol. Cell 42, 9-22
14. Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Crystal structures of c-Src reveal features of its autoinhibitory mechanism Mol. Cell 3, 629-638
15. Osusky, M., Taylor, S. J., and Shalloway, D. (1995) Autophosphorylation of purified c-Src at its primary negative regulation site J. Biol. Chem. 270, 25729-25732
16. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck Nature 385, 602-609
17. Johnson, L. N., Noble, M. E., and Owen, D. J. (1996) Active and inactive protein kinases: structural basis for regulation Cell 85, 149-158
18. Kornev, A. P., Taylor, S. S., and Ten Eyck, L. F. (2008) A helix scaffold for the assembly of active protein kinases Proc. Natl. Acad. Sci. U.S.A. 105, 14377-14382
19. Kornev, A. P. and Taylor, S. S. (2010) Defining the conserved internal architecture of a protein kinase Biochim. Biophys. Acta 1804, 440-444
20. Hennequin, L. F., Allen, J., Breed, J., Curwen, J., Fennell, M., Green, T. P., Lambert-van der Brempt, C., Morgentin, R., Norman, R. A., Olivier, A., Otterbein, L., Ple, P. A., Warin, N., and Costello, G. (2006) N -(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy] -5-(tetrahydro-2 H -pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor J. Med. Chem. 49, 6465-6488
21. Krishnamurty, R., Brigham, J. L., Leonard, S. E., Ranjitkar, P., Larson, E. T., Dale, E. J., Merritt, E. A., and Maly, D. J. (2013) Active site profiling reveals coupling between domains in SRC-family kinases Nat. Chem. Biol. 9, 43-50
22. Marcotte, D. J., Liu, Y. T., Arduini, R. M., Hession, C. A., Miatkowski, K., Wildes, C. P., Cullen, P. F., Hong, V., Hopkins, B. T., Mertsching, E., Jenkins, T. J., Romanowski, M. J., Baker, D. P., and Silvian, L. F. (2010) Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases Protein Sci. 19, 429-439
23. Zhou, T., Commodore, L., Huang, W. S., Wang, Y., Thomas, M., Keats, J., Xu, Q., Rivera, V. M., Shakespeare, W. C., Clackson, T., Dalgarno, D. C., and Zhu, X. (2011) Structural mechanism of the pan-BCR-ABL inhibitor ponatinib (AP24534): lessons for overcoming kinase inhibitor resistance Chem. Biol. Drug Des. 77, 1-11
24. Skora, L., Mestan, J., Fabbro, D., Jahnke, W., and Grzesiek, S. (2013) NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors Proc. Natl. Acad. Sci. U.S.A. 110, E4437-E4445
25. Young, M. A., Gonfloni, S., Superti-Furga, G., Roux, B., and Kuriyan, J. (2001) Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation Cell 105, 115-126
26. Ulmer, T. S., Werner, J. M., and Campbell, I. D. (2002) SH3-SH2 domain orientation in Src kinases: NMR studies of Fyn Structure 10, 901-911
27. Cowan-Jacob, S. W., Fendrich, G., Manley, P. W., Jahnke, W., Fabbro, D., Liebetanz, J., and Meyer, T. (2005) The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation Structure 13, 861-871
28. Sicilia, R. J., Hibbs, M. L., Bello, P. A., Bjorge, J. D., Fujita, D. J., Stanley, I. J., Dunn, A. R., and Cheng, H. C. (1998) Common in vitro substrate specificity and differential Src homology 2 domain accessibility displayed by two members of the Src family of protein-tyrosine kinases, c-Src and Hck J. Biol. Chem. 273, 16756-16763
29. Gonfloni, S., Williams, J. C., Hattula, K., Weijland, A., Wierenga, R. K., and Superti-Furga, G. (1997) The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src EMBO J. 16, 7261-7271
30. Briggs, S. D. and Smithgall, T. E. (1999) SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in Rat-2 fibroblasts J. Biol. Chem. 274, 26579-26583
31. LaFevre-Bernt, M., Sicheri, F., Pico, A., Porter, M., Kuriyan, J., and Miller, W. T. (1998) Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue J. Biol. Chem. 273, 32129-32134
32. Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., and Wierenga, R. K. (1997) The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions J. Mol. Biol. 274, 757-775
33. Hatzivassiliou, G., Song, K., Yen, I., Brandhuber, B. J., Anderson, D. J., Alvarado, R., Ludlam, M. J., Stokoe, D., Gloor, S. L., Vigers, G., Morales, T., Aliagas, I., Liu, B., Sideris, S., Hoeflich, K. P., Jaiswal, B. S., Seshagiri, S., Koeppen, H., Belvin, M., Friedman, L. S., and Malek, S. (2010) RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth Nature 464, 431-435
34. Poulikakos, P. I., Zhang, C., Bollag, G., Shokat, K. M., and Rosen, N. (2010) RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature 464, 427-430
35. Chan, T. O., Zhang, J., Rodeck, U., Pascal, J. M., Armen, R. S., Spring, M., Dumitru, C. D., Myers, V., Li, X., Cheung, J. Y., and Feldman, A. M. (2011) Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity Proc. Natl. Acad. Sci. U.S.A. 108, E1120-E1127
36. Andraos, R., Qian, Z., Bonenfant, D., Rubert, J., Vangrevelinghe, E., Scheufler, C., Marque, F., Regnier, C. H., De Pover, A., Ryckelynck, H., Bhagwat, N., Koppikar, P., Goel, A., Wyder, L., Tavares, G., Baffert, F., Pissot-Soldermann, C., Manley, P. W., Gaul, C., Voshol, H., Levine, R. L., Sellers, W. R., Hofmann, F., and Radimerski, T. (2012) Modulation of activation-loop phosphorylation by JAK inhibitors is binding mode dependent Cancer Discovery 2, 512-523
37. Hari, S. B., Merritt, E. A., and Maly, D. J. (2014) Conformation- selective ATP-competitive inhibitors control regulatory interactions and noncatalytic functions of mitogen-activated protein kinases Chem. Biol. 21, 628-625
38. Sullivan, J. E., Holdgate, G. A., Campbell, D., Timms, D., Gerhardt, S., Breed, J., Breeze, A. L., Bermingham, A., Pauptit, R. A., Norman, R. A., Embrey, K. J., Read, J., VanScyoc, W. S., and Ward, W. H. (2005) Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase Biochemistry 44, 16475-16490
39. Murphy, S. M., Bergman, M., and Morgan, D. O. (1993) Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae Mol. Cell. Biol. 13, 5290-5300
40. Okada, M., Nada, S., Yamanashi, Y., Yamamoto, T., and Nakagawa, H. (1991) CSK: a protein-tyrosine kinase involved in regulation of src family kinases J. Biol. Chem. 266, 24249-24252
41. Cole, P. A., Shen, K., Qiao, Y., and Wang, D. (2003) Protein tyrosine kinases Src and Csk: a tail's tale Curr. Opin. Chem. Biol. 7, 580-585
42. Sondhi, D., Xu, W., Songyang, Z., Eck, M. J., and Cole, P. A. (1998) Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism Biochemistry 37, 165-172
43. Hill, Z. B., Perera, B. G., Andrews, S. S., and Maly, D. J. (2012) Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors ACS Chem. Biol. 7, 487-495
44. Pan, Z., Scheerens, H., Li, S. J., Schultz, B. E., Sprengeler, P. A., Burrill, L. C., Mendonca, R. V., Sweeney, M. D., Scott, K. C., Grothaus, P. G., Jeffery, D. A., Spoerke, J. M., Honigberg, L. A., Young, P. R., Dalrymple, S. A., and Palmer, J. T. (2007) Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase ChemMedChem. 2, 58-61
45. Roskoski, R., Jr. (2005) Src kinase regulation by phosphorylation and dephosphorylation Biochem. Biophys. Res. Commun. 331, 1-14
46. Bjorge, J. D., Pang, A., and Fujita, D. J. (2000) Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines J. Biol. Chem. 275, 41439-41446
47. Shan, Y., Seeliger, M. A., Eastwood, M. P., Frank, F., Xu, H., Jensen, M. O., Dror, R. O., Kuriyan, J., and Shaw, D. E. (2009) A conserved protonation-dependent switch controls drug binding in the Abl kinase Proc. Natl. Acad. Sci. U.S.A. 106, 139-144
48. Alvarado, J. J., Betts, L., Moroco, J. A., Smithgall, T. E., and Yeh, J. I. (2010) Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism J. Biol. Chem. 285, 35455-35461
49. Ayrapetov, M. K., Wang, Y. H., Lin, X., Gu, X., Parang, K., and Sun, G. (2006) Conformational basis for SH2-Tyr(P)527 binding in Src inactivation J. Biol. Chem. 281, 23776-23784
50. Lerner, E. C. and Smithgall, T. E. (2002) SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo Nat. Struct. Biol. 9, 365-369
51. Moarefi, I., LaFevre-Bernt, M., Sicheri, F., Huse, M., Lee, C. H., Kuriyan, J., and Miller, W. T. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement Nature 385, 650-653
52. Smart, J. E., Oppermann, H., Czernilofsky, A. P., Purchio, A. F., Erikson, R. L., and Bishop, J. M. (1981) Characterization of sites for tyrosine phosphorylation in the transforming protein of Rous sarcoma virus (pp60v-src) and its normal cellular homologue (pp60c-src) Proc. Natl. Acad. Sci. U.S.A. 78, 6013-6017
53. Wang, L., Perera, B. G., Hari, S. B., Bhhatarai, B., Backes, B. J., Seeliger, M. A., Schurer, S. C., Oakes, S. A., Papa, F. R., and Maly, D. J. (2012) Divergent allosteric control of the IRE1alpha endoribonuclease using kinase inhibitors Nat. Chem. Biol. 8, 982-989
54. Koppikar, P., Bhagwat, N., Kilpivaara, O., Manshouri, T., Adli, M., Hricik, T., Liu, F., Saunders, L. M., Mullally, A., Abdel-Wahab, O., Leung, L., Weinstein, A., Marubayashi, S., Goel, A., Gonen, M., Estrov, Z., Ebert, B. L., Chiosis, G., Nimer, S. D., Bernstein, B. E., Verstovsek, S., and Levine, R. L. (2012) Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy Nature 489, 155-159
55. Seeliger, M. A., Young, M., Henderson, M. N., Pellicena, P., King, D. S., Falick, A. M., and Kuriyan, J. (2005) High yield bacterial expression of active c-Abl and c-Src tyrosine kinases Protein Sci. 14, 3135-3139
56. Johnson, S. M., Murphy, R. C., Geiger, J. A., DeRocher, A. E., Zhang, Z., Ojo, K. K., Larson, E. T., Perera, B. G., Dale, E. J., He, P., Reid, M. C., Fox, A. M., Mueller, N. R., Merritt, E. A., Fan, E., Parsons, M., Van Voorhis, W. C., and Maly, D. J. (2012) Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity J. Med. Chem. 55, 2416-2426
57. Apsel, B., Blair, J. A., Gonzalez, B., Nazif, T. M., Feldman, M. E., Aizenstein, B., Hoffman, R., Williams, R. L., Shokat, K. M., and Knight, Z. A. (2008) Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases Nat. Chem. Biol. 4, 691-699
58. Brigham, J. L., Perera, B. G., and Maly, D. J. (2013) A hexylchloride-based catch-and-release system for chemical proteomic applications ACS Chem. Biol. 8, 691-699
59. Zapf, C. W., Gerstenberger, B. S., Xing, L., Limburg, D. C., Anderson, D. R., Caspers, N., Han, S., Aulabaugh, A., Kurumbail, R., Shakya, S., Li, X., Spaulding, V., Czerwinski, R. M., Seth, N., and Medley, Q. G. (2012) Covalent inhibitors of interleukin-2 inducible T cell kinase (Itk) with nanomolar potency in a whole-blood assay J. Med. Chem. 55, 10047-10063
60. Chen, W. and Loury, D. J. (2013) Preparation of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine derivatives as Btk kinase inhibitors, p 191, Patent US8377946 B1.